Sleep Stimulation to Enhance Waste Clearance in the Brain
Condition(s) studied
Investigational drug(s) / intervention(s)
Closed-loop acoustic stimulation: At-home sleep will be monitored using an EEG headband. Non-awakening auditory stimuli will be delivered during non-rapid eye movement sleep (NREM), timed to the ascending phase of slow waves, using either active or control (sham) conditions.
Study summary
This study aims to examine whether multi-night closed-loop auditory stimulation (CLAS) during sleep can enhance waste clearance and memory consolidation in healthy adults and older adults with subjective cognitive decline or mild cognitive impairment who exhibit elevated brain amyloid levels identified through prior clinical screening. Specifically, the study investigates whether sleep stimulation increases the clearance of plasma biomarkers related to neurodegeneration, improves the brain's waste clearance system, and supports memory consolidation. Participants will undergo five nights each of CLAS and sham (no stimulation) interventions, with a washout period in between. They will also complete clinical assessments, including MRI scans, blood sample collection, and cognitive testing, and will keep track of subjective sleep quality, sleepiness, mood, and fatigue throughout the interventions.
Eligibility
Primary outcome measure(s)
- Plasma biomarkers — Blood samples will be collected the morning after each intervention phase. Interventions are separated by one week.
Levels of plasma biomarkers associated with neurodegeneration and brain health will be compared between stimulation and sham interventions.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital Universitaire de Bruxelles | Brussels | Belgium |
More Erasme University Hospital trials in Belgium
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07051239 on ClinicalTrials.gov ↗ ← All trials in Belgium